Impact of pharmacogenetics on CNS side effects related to efavirenz

Author： Sánchez Martín Almudena Cabrera Figueroa Salvador Cruz Guerrero Raquel Hurtado Liliana Porras Hurlé Alfonso Dominguez-Gil Carracedo Álvarez Ángel

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.14, Iss.10, 2013-07, pp. : 1167-1178

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efavirenz can cause early transient CNS effects in children

Inpharma, Vol. 1, Iss. 1278, 2001-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects prediction

By Zhang Jian-Ping Malhotra Anil K

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 1, 2011-01 ,pp. : 9-37

Informa Healthcare

Access to resources Recommend Favorite

Efavirenz: CNS disorders: case report

Reactions Weekly, Vol. 1, Iss. 1174, 2007-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Physicians underestimate frequency of SSRI-related side effects

Reactions Weekly, Vol. 1, Iss. 1019, 2004-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

The impact of pharmacogenetics for migraine

By Ophoff

European Journal of Pharmacology, Vol. 413, Iss. 1, 2001-02 ,pp. : 1-10

Elsevier

Access to resources Recommend Favorite